Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

Sherry Shen,Joseph M. Unger,Katherine D. Crew,Cathee Till,Heather Greenlee,Julie R. Gralow,Shaker R. Dakhil,Lori M. Minasian,James L. Wade,Michael J. Fisch,Norah Lynn Henry,Dawn L. Hershman

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

2018

Sherry Shen
Joseph M. Unger
Katherine D. Crew
Cathee Till
Heather Greenlee
Julie R. Gralow
Shaker R. Dakhil
Lori M. Minasian
James L. Wade
Michael J. Fisch
Norah Lynn Henry
Dawn L. Hershman

10000Background: Although aromatase inhibitors (AIs) prolong survival in postmenopausal women with breast cancer (BC), AI arthralgia can lead to discontinuation. Obese patients have higher rates of...

Keywords:

Breast cancer
Aromatase inhibitor
Pathology
Cancer research
Medicine
Fatty acid
Aromatase
omega 3 fatty acid
Discontinuation
Oncology
Internal medicine
postmenopausal women

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations